文献速递运动医学关节外科

膝关节初次自体软骨细胞植入与骨髓刺激失败后ACI的系统综述

Primary Autologous Chondrocyte Implantation of the Knee Versus Autologous Chondrocyte Implantation After Failed Marrow Stimulation: A Systematic Review.
PubMed 文献 · Am J Sports Med · 2020-11-06

该系统综述纳入7项研究共1335例患者,比较膝关节初次自体软骨细胞植入(ACI)与骨髓刺激失败后二次ACI的失败率与患者报告结局。初次ACI组治疗失败率为14.0%,二次ACI组为27.6%(P < .00001);部分研究报告初次ACI的主观评分更优,另有2项研究报告两组患者报告结局无显著差异。

要点

  • 二次ACI治疗失败率显著高于初次ACI(27.6% vs 14.0%,P < .00001)。
  • 初次与二次ACI均可获得患者报告的改善。
  • 部分研究显示初次ACI的主观疼痛与功能评分优于二次ACI。

核心结论

  • 初次或二次膝关节ACI均可预期患者报告的症状改善,但二次ACI的治疗失败风险显著更高,主观结局可能更差。

研究设计与样本

  • 系统综述,检索PubMed、Embase和Cochrane Library数据库。
  • 纳入7项研究(2项2级研究、5项3级研究),共1335例患者(初次ACI组838例,二次ACI组497例)。
  • 纳入研究的患者平均年龄34.2岁,平均病灶大小5.43 cm2。

主要发现

  • 初次ACI组治疗失败率为14.0%,二次ACI组为27.6%(P < .00001)。
  • 4项研究报告了患者报告结局;1项研究发现初次ACI组的主观IKDC评分(P = .011)、VAS疼痛评分(P = .028)和VAS功能评分(P = .005)显著更优。
  • 另1项研究发现初次ACI组的KOOS疼痛评分(P = .034)、KOOS日常生活活动评分(P = .024)、VAS疼痛评分(P = .014)和VAS功能评分(P = .032)显著更优。
  • 2项研究发现初次ACI组与二次ACI组患者报告结局无显著差异(P < .05)。

关键数值与推荐

  • 治疗失败:初次ACI组14.0%,二次ACI组27.6%(P < .00001)。
  • 主观IKDC评分P = .011、VAS疼痛评分P = .028、VAS功能评分P = .005(初次ACI更优,1项研究)。
  • KOOS疼痛评分P = .034、KOOS日常生活活动评分P = .024、VAS疼痛评分P = .014、VAS功能评分P = .032(初次ACI更优,1项研究)。

临床怎么用

  • 向骨髓刺激失败后接受二次ACI的患者告知其治疗失败风险高于初次ACI。
  • 初次ACI与二次ACI均可作为改善患者报告症状的选择。
  • 结合病灶条件与既往手术史个体化选择ACI时机。

局限性

  • 纳入研究以3级研究为主(5项3级、2项2级),证据等级有限。
  • 仅4项研究报告患者报告结局,且各研究间结局指标不完全一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Marrow stimulation (MST) surgery, which includes microfracture, subchondral drilling, and abrasion arthroplasty, and autologous chondrocyte implantation (ACI) are 2 surgical options to treat articular cartilage lesions in the knee joint. Recent studies have suggested worse outcomes when ACI is used after failed MST. PURPOSE: To investigate the failure rates and clinical outcomes of primary knee ACI versus ACI after failed MST surgery (secondary ACI). STUDY DESIGN: Systematic review. METHODS: A systematic review was performed by searching the PubMed, Embase, and Cochrane Library databases to identify studies evaluating clinical outcomes of patients undergoing primary versus secondary ACI of the knee joint. The search terms used were as follows: "knee" AND ("autologous chondrocyte implantation" OR "osteochondral allograft") AND (microfracture OR "marrow stimulation"). Patients undergoing primary ACI (group A) were compared with those undergoing secondary ACI (group B) based on treatment failure rates and patient-reported outcomes (PROs). RESULTS: Seven studies (2 level 2 studies, 5 level 3 studies) were identified and met inclusion criteria, including a total of 1335 patients (group A: n = 838; group B: n = 497). The average patient age in all studies was 34.2 years, and the average lesion size was 5.43 cm2. Treatment failure occurred in 14.0% of patients in group A and 27.6% of patients in group B (P < .00001). Four studies reported PROs. One study found significantly better Subjective International Knee Documentation Committee scores (P = .011), visual analog scale (VAS) pain scores (P = .028), and VAS function scores (P = .005) in group A. Another study found significantly better Knee injury and Osteoarthritis Outcome Score (KOOS) Pain scores (P = .034), KOOS Activities of Daily Living scores (P = .024), VAS pain scores (P = .014), and VAS function scores (P = .032) in group A. Two studies found no significant difference in PROs between groups A and B (P < .05). CONCLUSION: Patient-reported improvement can be expected in patients undergoing primary or secondary ACI of the knee joint. Patients undergoing secondary ACI have a significantly higher risk of treatment failure and may have worse subjective outcomes compared with patients undergoing primary ACI.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Schuette HB, Kraeutler MJ, Schrock JB, et al. Primary Autologous Chondrocyte Implantation of the Knee Versus Autologous Chondrocyte Implantation After Failed Marrow Stimulation: A Systematic Review. Am J Sports Med. 2020. PMID: 33156690. doi:10.1177/0363546520968284

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。